Most Recent
There is a time for everything, as Ecclesiastes says, but who has time for class actions that plead everything and the kitchen sink, a vexed judge wants to know, calling on litigants to home in on the real contest in their cases.
A judge has ruled that building materials giant Boral breached its continuous disclosure obligations, in a win for a class action, but will wait on the High Court's ruling in cases against CBA before deciding whether shareholders have established damages.
NSW Police has argued the lead plaintiff in a class action over strip searches at music festivals should only receive $33,000 in damages rather than $93,000 and is challenging a finding that the strip searches were done “as a matter of routine”.
Industrial technology company Delta Building Automation has lost its fight over a finding that it attempted to rig a bid for construction work on the National Gallery of Australia and must pay a $1.5 million penalty.
The Transport Workers Union and a judge have debated how much of a $90 million penalty handed to Qantas should be given to 1,820 workers who were unlawfully outsourced during the COVID-19 pandemic.
A judge has hit Qantas with a $90 million penalty for unlawfully outsourcing its ground crew staff during the COVID-19 pandemic, saying the airline was “the wrong kind of sorry”.
Qantas should pay a penalty of the “highest order” for outsourcing its ground crew staff during the COVID pandemic, a union has argued, while a judge has questioned if he needs to send a message that "you can't play the court for a fool".
In a loss for the ACCC, the High Court has found builder J Hutchinson did not arrive at an anti-competitive understanding with the CFMEU merely by yielding to a threat of industrial action.
In deciding an evidentiary dispute in a shareholder class action against building materials giant Boral, a judge has sounded off over the increasing costs of expert evidence produced in group proceedings.
The High Court has settled a 16-year battle between the federal government and Sanofi over alleged excess subsidies it paid after a judge blocked the release of a generic version of blood thinner Plavix, saying its job was not to “resurrect” a dead case.